Clinical Trials


The COMBO Plus Dual Therapy stent with EPC capturing has been clinically evaluated in numerous randomized studies and registries, demonstrating safety and efficacy over a broad spectrum of patients as well as providing short DAPT flexibility where necessary.

Prospective, multicentre, all-comers, European registry. NCT01874002

Single-center study with serial OCT assessment of COMBO’s healing profile. NCT01274234, NCT01756807, NCT02263313

Prospective, multicenter, all-comers’ registry with patients from Asia and Europe. NCT02183454

Prospective, single-center, AMI Singapore registry.

Prospective, single-center, randomized study in STEMI patients assessing endothelial function response after stenting. NCT04202172

Prospective multicentre, all comers, randomized trial. NCT03216733

Prospective, multicentre, randomized study for China approval. NCT02542007

Prospective, multicentre, randomized study in acute coronary syndrome patients with shortened DAPT NCT02118870

Prospective, multicentre randomized trial for Japanese approval & US feasibility. NCT02073565

Prospective, multicentre, randomized OCT study. NCT01405287

Prospective, multicentre randomized first-in-man study for CE approval. NCT00967902